![Christopher McAleer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher McAleer worked as Chief Scientist at Hesperos, Inc. and as Chief Scientific Officer at AIM ImmunoTech, Inc. from 2022 to 2024.
Dr. McAleer completed undergraduate studies at West Chester University of Pennsylvania and earned graduate and doctorate degrees from the University of Central Florida.
| Companies | Position | End |
|---|---|---|
| AIM IMMUNOTECH INC. | Chief Tech/Sci/R&D Officer | 01/02/2024 |
Hesperos, Inc.
 Hesperos, Inc. Pharmaceuticals: OtherHealth Technology Manufactures drugs and medicines | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
AIM ImmunoTech, Inc.
 AIM ImmunoTech, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical drugs | Health Technology |
University of Central Florida
 University of Central Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Chester University of Pennsylvania
 West Chester University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hesperos, Inc.
Hesperos, Inc. Pharmaceuticals: OtherHealth Technology Manufactures drugs and medicines | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
